Abstract
The synthesis of a series of novel 3-piperazinylmethyl-3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles as novel dual 5-HT reuptake inhibitors and alpha(2)-adrenoceptor antagonists is described. Their affinity at the three different human alpha(2)-adrenoceptor subtypes and the 5-HT transporter site is reported. The in vivo activity of the compounds was measured in two different assays: (1). inhibition of pCA-induced excitation, which evaluates the ability to block the central 5-HT transporter, and (2). inhibition of xylazine-induced loss of righting, which evaluates the ability to block central alpha(2)-adrenoceptors.
MeSH terms
-
Adrenergic alpha-Antagonists / chemical synthesis*
-
Adrenergic alpha-Antagonists / pharmacology*
-
Animals
-
Antidepressive Agents / chemical synthesis*
-
Antidepressive Agents / pharmacology*
-
Carrier Proteins / metabolism
-
Isoxazoles / chemical synthesis*
-
Isoxazoles / pharmacology
-
Membrane Glycoproteins / metabolism
-
Membrane Transport Proteins*
-
Molecular Structure
-
Nerve Tissue Proteins*
-
Rats
-
Selective Serotonin Reuptake Inhibitors / chemical synthesis*
-
Selective Serotonin Reuptake Inhibitors / pharmacology
-
Serotonin Plasma Membrane Transport Proteins
-
Stereoisomerism
-
Structure-Activity Relationship
-
Xylazine / antagonists & inhibitors
Substances
-
Adrenergic alpha-Antagonists
-
Antidepressive Agents
-
Carrier Proteins
-
Isoxazoles
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors
-
Slc6a4 protein, rat
-
Xylazine